| David H Brendel, MD | |
|
115 Mill St, Belmont, MA 02478-1041 | |
| (617) 855-3498 | |
| Not Available |
| Full Name | David H Brendel |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 115 Mill St, Belmont, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609834548 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 160341 (Massachusetts) | Primary |
| Entity Name | Walden Behavioral Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992778781 PECOS PAC ID: 0042121659 Enrollment ID: O20041001000593 |
News Archive
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
John W. Tsuang, M.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), in conjunction with Steven J. Shoptaw, Ph.D., from the UCLA Department of Family Medicine, is spearheading a Phase I clinical safety trial that for the first time examines the effects of Ibudilast when administered with metamphetamine (MA), an addictive stimulant that is closely related to amphetamine.
Tanabe Research Labs USA, Inc. (TRL) today announced commencement of its new operations at the TRL facility in San Diego with a focus on biological drugs for the treatment of autoimmune diseases. TRL began its new activities in May with the appointment of three new senior executives: Masaki Yamada, Ph.D., Chief Executive Officer; Toshihiro Hosaka, Ph.D., Senior Vice President, and Roland Newman, Ph.D., VP and Chief Scientific Officer.
[T]he GOP may be positioning itself to become the dog that caught the car. Political and policy uncertainty is perhaps inevitable given the range of what the Court could do. But the Republicans need a more coherent strategy. ... An orderly unwinding of ObamaCare was always going to be difficult. But based on its disarray and confusion so far, the GOP may be making it harder.
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients with complex coronary lesions. Similar clinical outcomes compared to the PCI procedure performed manually were reported.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David H Brendel, MD 115 Mill St, Belmont, MA 02478-1041 Ph: (617) 855-3498 | David H Brendel, MD 115 Mill St, Belmont, MA 02478-1041 Ph: (617) 855-3498 |
News Archive
Novartis announced today the results of a pivotal Phase II trial demonstrating that patients with locally advanced (laBCC) or metastatic basal cell carcinoma (mBCC) taking the investigational oral compound LDE225 (sonidegib) had marked and sustained tumor shrinkage after a median follow-up of 13.9 months.
John W. Tsuang, M.D., principal investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), in conjunction with Steven J. Shoptaw, Ph.D., from the UCLA Department of Family Medicine, is spearheading a Phase I clinical safety trial that for the first time examines the effects of Ibudilast when administered with metamphetamine (MA), an addictive stimulant that is closely related to amphetamine.
Tanabe Research Labs USA, Inc. (TRL) today announced commencement of its new operations at the TRL facility in San Diego with a focus on biological drugs for the treatment of autoimmune diseases. TRL began its new activities in May with the appointment of three new senior executives: Masaki Yamada, Ph.D., Chief Executive Officer; Toshihiro Hosaka, Ph.D., Senior Vice President, and Roland Newman, Ph.D., VP and Chief Scientific Officer.
[T]he GOP may be positioning itself to become the dog that caught the car. Political and policy uncertainty is perhaps inevitable given the range of what the Court could do. But the Republicans need a more coherent strategy. ... An orderly unwinding of ObamaCare was always going to be difficult. But based on its disarray and confusion so far, the GOP may be making it harder.
A first-of-its kind study using robotic technology to remotely control coronary guidewires and stents reported on the feasibility of performing percutaneous coronary intervention (PCI) on patients with complex coronary lesions. Similar clinical outcomes compared to the PCI procedure performed manually were reported.
› Verified 2 days ago
Evan D Murray, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 115 Mill St, Mclean Hospital, Belmont, MA 02478 Phone: 617-855-2354 Fax: 617-855-3731 | |
Stephane Poulin, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Mclean Hospital, 115 Mill Street, Belmont, MA 02478 Phone: 617-855-2183 | |
Dr. Emily J Deringer, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3621 | |
Dr. Marni Joy Chanoff, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3937 | |
Prof. Bruce Michael Cohen, M.D., PH.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3227 Fax: 617-855-3670 | |
John D Gambill, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 29 Stults Rd, Belmont, MA 02478 Phone: 617-489-2645 | |
Ashley Beaulieu, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 115 Mill St, Belmont, MA 02478 Phone: 617-855-3117 |